We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible

By LabMedica International staff writers
Posted on 22 Apr 2025

Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. More...

For a long time, polymerase chain reaction (PCR) has been the gold standard for analyzing DNA changes. With the onset of the COVID-19 pandemic, the term "PCR" became widely recognized. However, PCR tests are expensive, time-consuming, and require specialized lab equipment and trained personnel. While PCR-based genetic testing gained significant attention during the pandemic, light-based methods are now offering a PCR-free alternative for genetic analysis.

Researchers at Osaka Metropolitan University (Osaka, Japan) have developed a groundbreaking light-induced DNA detection method that employs heterogeneous probe particles. This innovative technique enables highly sensitive and rapid genetic analysis without the need for PCR amplification. This advance promises to make genetic testing faster, more affordable, and more precise, benefiting fields like medicine, environmental science, and portable diagnostics. Unlike PCR, which amplifies DNA sequences by creating millions of copies for detection, this new approach directly identifies DNA by concentrating it and enhancing its specificity through optical forces and the photothermal effect. In their study, published in ACS Sensors, the researchers used heterogeneous probe particles, including gold nanoparticles and polystyrene microparticles, to create a detection system. These probes are short DNA sequences that are designed to bind with complementary sequences in the target DNA.

This process, known as DNA hybridization, results in the formation of detectable DNA pairs through fluorescence. The solution containing the target DNA and probe particles was then irradiated with laser light. When the particle size aligns with the laser wavelength, a phenomenon called Mie scattering occurs, which generates optical forces that move the particles and speed up DNA hybridization. The gold nanoparticles absorb the laser light, producing localized heat, also known as the photothermal effect, which further enhances the specificity of the hybridization. By eliminating the need for PCR amplification, this method reduces both the cost and complexity of genetic testing while delivering faster results. This innovation has the potential to make genetic analysis more accessible, with wide-ranging applications in healthcare and personal health tracking.

“Our light-induced method detects DNA without the need for PCR,” wrote the study’s lead authors. “Using just about five minutes of laser light irradiation, our method demonstrated great potential for accurate mutation detection with a sensitivity one order of magnitude higher than that of digital PCR. We aim to apply this PCR-free technology to high-sensitivity cancer diagnostics, quantum life science research, and even at-home or environmental DNA testing.”

Related Links:
Osaka Metropolitan University


Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HbA1c Test
HbA1c Rapid Test
New
Silver Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.